Dr. Scott Todd

Dr. Scott Todd

Dr. Scott Todd serves Compassion International as Senior Vice President of International Partner Development and is a renowned Advocate for eradicating extreme global poverty within this generation’s lifetime.

Dr. Scott Todd
Dr. Scott Todd

Expertise: Child Survival, HIV/AIDS, Malaria, Global Poverty, Global Partner Alliance, Wydick Research

Dr. Scott Todd serves Compassion International as Senior Vice President of Global Advocacy and is a renowned Advocate for eradicating extreme global poverty within this generation’s lifetime.

Dr. Todd serves on the Board for North America’s largest network of Christian relief and development organizations (ACCORD). He is the author of Fast Living: How the Church Will End Extreme Poverty and co-author of both Shared Strength: Exploring Cross-Cultural Christian Partnerships as well as Relentless Hope.

Dr. Todd is one of the architects and Board Chairman of the Live58 Initiative, an unprecedented, action-based partnership of ten of the world’s leading Christian poverty-fighting organizations working together to end extreme poverty by 2035. Each organization, including Compassion International, focuses on its core area of expertise. The Live58 movement is based on the themes within Isaiah 58. Dr. Todd served as co-producer of 58: The Film, and his work surrounding this initiative is focused on sharing the theological foundation, hard statistics and human stories that open the world’s eyes to the war on poverty and the role we can all play in its demise.

“In the past 20 years, extreme poverty has been cut in half. That’s in just one generation!” says Dr. Todd. “Progress is being made across the globe—from the decline in childhood disease death rates to curbing the spread of HIV. The numbers are astounding! Yes, the needs are still great, but the tyranny of extreme poverty is being broken.”

Dr. Todd was previously a Postdoctoral Fellow at Stanford University and later a Professor of Molecular, Cell and Developmental Biology at Kansas State University. However, his personal experiences with the poor forever changed him and became key drivers in what would become his life’s work.

One such experience was with an HIV-infected child named Jacqueline. Dr. Todd was fighting to save her life using anti-retroviral drugs, but she was too weak and her condition too advanced. Jacqueline died, and Dr. Todd made a promise to honor her memory. “I told myself I’d do whatever it takes, with whatever influence God grants, to not be too late for the rest of the children,” he says.

Dr. Todd’s medical expertise fueled his path at Compassion, including his role as International Health Specialist, which entailed developing and integrating health programs at a global level. As Director of the AIDS Initiative for Compassion, he established protocols for testing hundreds of thousands of children for HIV and providing thousands with anti-retroviral drugs.

“God has given me countless experiences with the poor. They have all woven into my life and helped shape who I am. I hope to continue to be a servant to God by ministering to the poor, to “loose the chains of injustice and untie the cords of the yoke, to set the oppressed free, to share food with the hungry and provide the poor wanderer with shelter, to clothe the naked and not turn away from our own flesh and blood.” (Adapted from Isaiah 58: 6-7)


  • 1996-1998 Postdoctoral Fellow – Oncology
    Stanford University Medical Center, Division of Oncology
  • 1991-1996 Ph.D., Immunology
    University of California, San Diego
  • 1987-1991 B.S., Microbiology, Cum Laude
    Kansas State University, Manhattan, KS


  • National Institutes of Health, Grant Winner, 2001-2004
  • American Cancer Society Grant Winner, 2003
  • Presidential Award for Excellence in Undergraduate Education, 2002
  • National Science Foundation – First Award Winner, 2000
  • Lymphoma Research Foundation Scholar, 1997 & 1998
  • NIH Postdoctoral Fellowship (NCI) – Stanford, 1997, 1998
  • ARCS scholar
  • State of Kansas Scholar

‘Inhibition of Hepatitis C Virus Envelop Protein E2 Binding to its Cellular Receptor, CD81, by Imidazole-4,5-Docarboxamide Derivatives’
Co-inventors: Paul W. Baures and Scott C. Todd

English and Greek

Biking, hiking, golf and my family

U.S. Media Contacts
Tim Glenn

(719) 272-5377

Becca Bishop

(719) 272-5109

For all non-media related inquiries, please call (800) 336-7676, Monday through Friday, 7 a.m. to 5:30 p.m. MT.